nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Alkylating Activity—Carmustine—melanoma	0.331	0.534	CiPCiCtD
Temozolomide—skin cancer—melanoma	0.328	1	CtDrD
Temozolomide—Alkylating Activity—Dacarbazine—melanoma	0.289	0.466	CiPCiCtD
Temozolomide—CYP3A4—Vemurafenib—melanoma	0.00456	0.744	CbGbCtD
Temozolomide—CYP3A4—Docetaxel—melanoma	0.00156	0.255	CbGbCtD
Temozolomide—Respiratory failure—Docetaxel—melanoma	0.000124	0.00269	CcSEcCtD
Temozolomide—Weight decreased—Bleomycin—melanoma	0.000123	0.00267	CcSEcCtD
Temozolomide—Pneumonia—Bleomycin—melanoma	0.000122	0.00265	CcSEcCtD
Temozolomide—Phosphatase alkaline increased—Docetaxel—melanoma	0.000122	0.00264	CcSEcCtD
Temozolomide—Pulmonary embolism—Docetaxel—melanoma	0.000122	0.00264	CcSEcCtD
Temozolomide—Muscular weakness—Carmustine—melanoma	0.000122	0.00263	CcSEcCtD
Temozolomide—Pancytopenia—Dactinomycin—melanoma	0.000121	0.00262	CcSEcCtD
Temozolomide—Dysphagia—Carmustine—melanoma	0.000119	0.00258	CcSEcCtD
Temozolomide—Neutropenia—Dactinomycin—melanoma	0.000119	0.00258	CcSEcCtD
Temozolomide—Stomatitis—Bleomycin—melanoma	0.000119	0.00257	CcSEcCtD
Temozolomide—Influenza like illness—Docetaxel—melanoma	0.000118	0.00257	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000117	0.00253	CcSEcCtD
Temozolomide—Skin exfoliation—Docetaxel—melanoma	0.000116	0.00252	CcSEcCtD
Temozolomide—Candida infection—Docetaxel—melanoma	0.000116	0.00252	CcSEcCtD
Temozolomide—Neuropathy—Docetaxel—melanoma	0.000115	0.00248	CcSEcCtD
Temozolomide—Pneumonia—Dactinomycin—melanoma	0.000114	0.00247	CcSEcCtD
Temozolomide—Pancytopenia—Carmustine—melanoma	0.000113	0.00245	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000113	0.00244	CcSEcCtD
Temozolomide—Neutropenia—Carmustine—melanoma	0.000111	0.00241	CcSEcCtD
Temozolomide—Decreased appetite—Vemurafenib—melanoma	0.000111	0.00241	CcSEcCtD
Temozolomide—Stomatitis—Dactinomycin—melanoma	0.000111	0.00239	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000111	0.00239	CcSEcCtD
Temozolomide—Fatigue—Vemurafenib—melanoma	0.00011	0.00239	CcSEcCtD
Temozolomide—Neoplasm—Docetaxel—melanoma	0.00011	0.00239	CcSEcCtD
Temozolomide—Haemoglobin—Bleomycin—melanoma	0.00011	0.00238	CcSEcCtD
Temozolomide—Constipation—Vemurafenib—melanoma	0.00011	0.00237	CcSEcCtD
Temozolomide—Haemorrhage—Bleomycin—melanoma	0.000109	0.00236	CcSEcCtD
Temozolomide—Hypoaesthesia—Bleomycin—melanoma	0.000109	0.00235	CcSEcCtD
Temozolomide—Hyperglycaemia—Carmustine—melanoma	0.000107	0.00233	CcSEcCtD
Temozolomide—Pneumonia—Carmustine—melanoma	0.000107	0.00231	CcSEcCtD
Temozolomide—Depression—Carmustine—melanoma	0.000106	0.00229	CcSEcCtD
Temozolomide—Neuropathy peripheral—Carmustine—melanoma	0.000104	0.00225	CcSEcCtD
Temozolomide—Stomatitis—Carmustine—melanoma	0.000104	0.00224	CcSEcCtD
Temozolomide—Urinary tract infection—Carmustine—melanoma	0.000103	0.00223	CcSEcCtD
Temozolomide—Thrombophlebitis—Docetaxel—melanoma	0.000102	0.00221	CcSEcCtD
Temozolomide—Hepatitis—Dactinomycin—melanoma	0.000102	0.00221	CcSEcCtD
Temozolomide—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000102	0.0022	CcSEcCtD
Temozolomide—Flushing—Bleomycin—melanoma	0.000101	0.00219	CcSEcCtD
Temozolomide—Body temperature increased—Vemurafenib—melanoma	0.000101	0.00219	CcSEcCtD
Temozolomide—Pharyngitis—Dactinomycin—melanoma	0.000101	0.00219	CcSEcCtD
Temozolomide—Deafness—Docetaxel—melanoma	9.9e-05	0.00214	CcSEcCtD
Temozolomide—Hepatic failure—Docetaxel—melanoma	9.86e-05	0.00213	CcSEcCtD
Temozolomide—Chills—Bleomycin—melanoma	9.8e-05	0.00212	CcSEcCtD
Temozolomide—Alopecia—Bleomycin—melanoma	9.65e-05	0.00209	CcSEcCtD
Temozolomide—Erythema multiforme—Dactinomycin—melanoma	9.63e-05	0.00208	CcSEcCtD
Temozolomide—Haemoglobin—Carmustine—melanoma	9.58e-05	0.00207	CcSEcCtD
Temozolomide—Haemorrhage—Carmustine—melanoma	9.53e-05	0.00206	CcSEcCtD
Temozolomide—Erythema—Bleomycin—melanoma	9.51e-05	0.00206	CcSEcCtD
Temozolomide—Hypoaesthesia—Carmustine—melanoma	9.49e-05	0.00205	CcSEcCtD
Temozolomide—Hallucination—Carmustine—melanoma	9.49e-05	0.00205	CcSEcCtD
Temozolomide—Hot flush—Docetaxel—melanoma	9.47e-05	0.00205	CcSEcCtD
Temozolomide—Flushing—Dactinomycin—melanoma	9.45e-05	0.00205	CcSEcCtD
Temozolomide—Hypersensitivity—Vemurafenib—melanoma	9.44e-05	0.00204	CcSEcCtD
Temozolomide—Oedema peripheral—Carmustine—melanoma	9.39e-05	0.00203	CcSEcCtD
Temozolomide—Menopausal symptoms—Docetaxel—melanoma	9.39e-05	0.00203	CcSEcCtD
Temozolomide—Connective tissue disorder—Carmustine—melanoma	9.37e-05	0.00203	CcSEcCtD
Temozolomide—Asthenia—Vemurafenib—melanoma	9.19e-05	0.00199	CcSEcCtD
Temozolomide—Visual impairment—Carmustine—melanoma	9.19e-05	0.00199	CcSEcCtD
Temozolomide—Chills—Dactinomycin—melanoma	9.14e-05	0.00198	CcSEcCtD
Temozolomide—Pruritus—Vemurafenib—melanoma	9.06e-05	0.00196	CcSEcCtD
Temozolomide—Alopecia—Dactinomycin—melanoma	9e-05	0.00195	CcSEcCtD
Temozolomide—Eye disorder—Carmustine—melanoma	8.91e-05	0.00193	CcSEcCtD
Temozolomide—Erythema—Dactinomycin—melanoma	8.87e-05	0.00192	CcSEcCtD
Temozolomide—Flushing—Carmustine—melanoma	8.85e-05	0.00192	CcSEcCtD
Temozolomide—Ill-defined disorder—Bleomycin—melanoma	8.82e-05	0.00191	CcSEcCtD
Temozolomide—Anaemia—Bleomycin—melanoma	8.79e-05	0.0019	CcSEcCtD
Temozolomide—Diarrhoea—Vemurafenib—melanoma	8.76e-05	0.0019	CcSEcCtD
Temozolomide—Malaise—Bleomycin—melanoma	8.57e-05	0.00186	CcSEcCtD
Temozolomide—Leukopenia—Bleomycin—melanoma	8.51e-05	0.00184	CcSEcCtD
Temozolomide—Dizziness—Vemurafenib—melanoma	8.47e-05	0.00183	CcSEcCtD
Temozolomide—Alopecia—Carmustine—melanoma	8.43e-05	0.00182	CcSEcCtD
Temozolomide—Mental disorder—Carmustine—melanoma	8.35e-05	0.00181	CcSEcCtD
Temozolomide—Ataxia—Docetaxel—melanoma	8.33e-05	0.0018	CcSEcCtD
Temozolomide—Malnutrition—Carmustine—melanoma	8.3e-05	0.0018	CcSEcCtD
Temozolomide—Erythema—Carmustine—melanoma	8.3e-05	0.0018	CcSEcCtD
Temozolomide—Cough—Bleomycin—melanoma	8.3e-05	0.0018	CcSEcCtD
Temozolomide—Dehydration—Docetaxel—melanoma	8.24e-05	0.00178	CcSEcCtD
Temozolomide—Ill-defined disorder—Dactinomycin—melanoma	8.23e-05	0.00178	CcSEcCtD
Temozolomide—Anaemia—Dactinomycin—melanoma	8.2e-05	0.00177	CcSEcCtD
Temozolomide—Vomiting—Vemurafenib—melanoma	8.14e-05	0.00176	CcSEcCtD
Temozolomide—Dry skin—Docetaxel—melanoma	8.12e-05	0.00176	CcSEcCtD
Temozolomide—Myalgia—Bleomycin—melanoma	8.1e-05	0.00175	CcSEcCtD
Temozolomide—Rash—Vemurafenib—melanoma	8.08e-05	0.00175	CcSEcCtD
Temozolomide—Dermatitis—Vemurafenib—melanoma	8.07e-05	0.00175	CcSEcCtD
Temozolomide—Back pain—Carmustine—melanoma	8.03e-05	0.00174	CcSEcCtD
Temozolomide—Headache—Vemurafenib—melanoma	8.02e-05	0.00174	CcSEcCtD
Temozolomide—Breast disorder—Docetaxel—melanoma	8e-05	0.00173	CcSEcCtD
Temozolomide—Discomfort—Bleomycin—melanoma	8e-05	0.00173	CcSEcCtD
Temozolomide—Malaise—Dactinomycin—melanoma	8e-05	0.00173	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Docetaxel—melanoma	7.98e-05	0.00173	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Docetaxel—melanoma	7.98e-05	0.00173	CcSEcCtD
Temozolomide—Leukopenia—Dactinomycin—melanoma	7.94e-05	0.00172	CcSEcCtD
Temozolomide—Confusional state—Bleomycin—melanoma	7.82e-05	0.00169	CcSEcCtD
Temozolomide—Vision blurred—Carmustine—melanoma	7.82e-05	0.00169	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Docetaxel—melanoma	7.81e-05	0.00169	CcSEcCtD
Temozolomide—Tremor—Carmustine—melanoma	7.78e-05	0.00168	CcSEcCtD
Temozolomide—Anaphylactic shock—Bleomycin—melanoma	7.76e-05	0.00168	CcSEcCtD
Temozolomide—Oedema—Bleomycin—melanoma	7.76e-05	0.00168	CcSEcCtD
Temozolomide—Infection—Bleomycin—melanoma	7.71e-05	0.00167	CcSEcCtD
Temozolomide—Anaemia—Carmustine—melanoma	7.67e-05	0.00166	CcSEcCtD
Temozolomide—Dysphagia—Docetaxel—melanoma	7.66e-05	0.00166	CcSEcCtD
Temozolomide—Agitation—Carmustine—melanoma	7.63e-05	0.00165	CcSEcCtD
Temozolomide—Nausea—Vemurafenib—melanoma	7.61e-05	0.00165	CcSEcCtD
Temozolomide—Thrombocytopenia—Bleomycin—melanoma	7.6e-05	0.00164	CcSEcCtD
Temozolomide—Myalgia—Dactinomycin—melanoma	7.55e-05	0.00163	CcSEcCtD
Temozolomide—Discomfort—Dactinomycin—melanoma	7.46e-05	0.00161	CcSEcCtD
Temozolomide—Leukopenia—Carmustine—melanoma	7.43e-05	0.00161	CcSEcCtD
Temozolomide—Anorexia—Bleomycin—melanoma	7.4e-05	0.0016	CcSEcCtD
Temozolomide—Pancytopenia—Docetaxel—melanoma	7.27e-05	0.00157	CcSEcCtD
Temozolomide—Oedema—Dactinomycin—melanoma	7.24e-05	0.00157	CcSEcCtD
Temozolomide—Convulsion—Carmustine—melanoma	7.19e-05	0.00156	CcSEcCtD
Temozolomide—Infection—Dactinomycin—melanoma	7.19e-05	0.00156	CcSEcCtD
Temozolomide—Hypertension—Carmustine—melanoma	7.17e-05	0.00155	CcSEcCtD
Temozolomide—Neutropenia—Docetaxel—melanoma	7.16e-05	0.00155	CcSEcCtD
Temozolomide—Thrombocytopenia—Dactinomycin—melanoma	7.09e-05	0.00153	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Bleomycin—melanoma	7.07e-05	0.00153	CcSEcCtD
Temozolomide—Myalgia—Carmustine—melanoma	7.07e-05	0.00153	CcSEcCtD
Temozolomide—Anxiety—Carmustine—melanoma	7.04e-05	0.00152	CcSEcCtD
Temozolomide—Paraesthesia—Bleomycin—melanoma	6.97e-05	0.00151	CcSEcCtD
Temozolomide—Weight increased—Docetaxel—melanoma	6.97e-05	0.00151	CcSEcCtD
Temozolomide—Weight decreased—Docetaxel—melanoma	6.93e-05	0.0015	CcSEcCtD
Temozolomide—Dyspnoea—Bleomycin—melanoma	6.92e-05	0.0015	CcSEcCtD
Temozolomide—Anorexia—Dactinomycin—melanoma	6.9e-05	0.00149	CcSEcCtD
Temozolomide—Pneumonia—Docetaxel—melanoma	6.87e-05	0.00149	CcSEcCtD
Temozolomide—Confusional state—Carmustine—melanoma	6.83e-05	0.00148	CcSEcCtD
Temozolomide—Infestation NOS—Docetaxel—melanoma	6.83e-05	0.00148	CcSEcCtD
Temozolomide—Infestation—Docetaxel—melanoma	6.83e-05	0.00148	CcSEcCtD
Temozolomide—Oedema—Carmustine—melanoma	6.77e-05	0.00147	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Docetaxel—melanoma	6.77e-05	0.00146	CcSEcCtD
Temozolomide—Decreased appetite—Bleomycin—melanoma	6.75e-05	0.00146	CcSEcCtD
Temozolomide—Infection—Carmustine—melanoma	6.73e-05	0.00146	CcSEcCtD
Temozolomide—Neuropathy peripheral—Docetaxel—melanoma	6.69e-05	0.00145	CcSEcCtD
Temozolomide—Stomatitis—Docetaxel—melanoma	6.65e-05	0.00144	CcSEcCtD
Temozolomide—Pain—Bleomycin—melanoma	6.64e-05	0.00144	CcSEcCtD
Temozolomide—Thrombocytopenia—Carmustine—melanoma	6.63e-05	0.00144	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Dactinomycin—melanoma	6.59e-05	0.00143	CcSEcCtD
Temozolomide—Anorexia—Carmustine—melanoma	6.46e-05	0.0014	CcSEcCtD
Temozolomide—Hepatobiliary disease—Docetaxel—melanoma	6.46e-05	0.0014	CcSEcCtD
Temozolomide—Feeling abnormal—Bleomycin—melanoma	6.39e-05	0.00138	CcSEcCtD
Temozolomide—Decreased appetite—Dactinomycin—melanoma	6.29e-05	0.00136	CcSEcCtD
Temozolomide—Fatigue—Dactinomycin—melanoma	6.24e-05	0.00135	CcSEcCtD
Temozolomide—Pain—Dactinomycin—melanoma	6.19e-05	0.00134	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Carmustine—melanoma	6.17e-05	0.00134	CcSEcCtD
Temozolomide—Urticaria—Bleomycin—melanoma	6.16e-05	0.00133	CcSEcCtD
Temozolomide—Haemoglobin—Docetaxel—melanoma	6.16e-05	0.00133	CcSEcCtD
Temozolomide—Body temperature increased—Bleomycin—melanoma	6.13e-05	0.00133	CcSEcCtD
Temozolomide—Haemorrhage—Docetaxel—melanoma	6.13e-05	0.00133	CcSEcCtD
Temozolomide—Hepatitis—Docetaxel—melanoma	6.13e-05	0.00133	CcSEcCtD
Temozolomide—Insomnia—Carmustine—melanoma	6.13e-05	0.00133	CcSEcCtD
Temozolomide—Hypoaesthesia—Docetaxel—melanoma	6.1e-05	0.00132	CcSEcCtD
Temozolomide—Paraesthesia—Carmustine—melanoma	6.08e-05	0.00132	CcSEcCtD
Temozolomide—Pharyngitis—Docetaxel—melanoma	6.08e-05	0.00132	CcSEcCtD
Temozolomide—Urinary tract disorder—Docetaxel—melanoma	6.05e-05	0.00131	CcSEcCtD
Temozolomide—Dyspnoea—Carmustine—melanoma	6.04e-05	0.00131	CcSEcCtD
Temozolomide—Oedema peripheral—Docetaxel—melanoma	6.04e-05	0.00131	CcSEcCtD
Temozolomide—Somnolence—Carmustine—melanoma	6.02e-05	0.0013	CcSEcCtD
Temozolomide—Connective tissue disorder—Docetaxel—melanoma	6.02e-05	0.0013	CcSEcCtD
Temozolomide—Urethral disorder—Docetaxel—melanoma	6.01e-05	0.0013	CcSEcCtD
Temozolomide—Feeling abnormal—Dactinomycin—melanoma	5.96e-05	0.00129	CcSEcCtD
Temozolomide—Gastrointestinal pain—Dactinomycin—melanoma	5.92e-05	0.00128	CcSEcCtD
Temozolomide—Visual impairment—Docetaxel—melanoma	5.9e-05	0.00128	CcSEcCtD
Temozolomide—Decreased appetite—Carmustine—melanoma	5.89e-05	0.00127	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Carmustine—melanoma	5.85e-05	0.00127	CcSEcCtD
Temozolomide—Erythema multiforme—Docetaxel—melanoma	5.79e-05	0.00125	CcSEcCtD
Temozolomide—Pain—Carmustine—melanoma	5.79e-05	0.00125	CcSEcCtD
Temozolomide—Constipation—Carmustine—melanoma	5.79e-05	0.00125	CcSEcCtD
Temozolomide—Eye disorder—Docetaxel—melanoma	5.73e-05	0.00124	CcSEcCtD
Temozolomide—Body temperature increased—Dactinomycin—melanoma	5.72e-05	0.00124	CcSEcCtD
Temozolomide—Abdominal pain—Dactinomycin—melanoma	5.72e-05	0.00124	CcSEcCtD
Temozolomide—Hypersensitivity—Bleomycin—melanoma	5.72e-05	0.00124	CcSEcCtD
Temozolomide—Cardiac disorder—Docetaxel—melanoma	5.69e-05	0.00123	CcSEcCtD
Temozolomide—Flushing—Docetaxel—melanoma	5.69e-05	0.00123	CcSEcCtD
Temozolomide—Feeling abnormal—Carmustine—melanoma	5.58e-05	0.00121	CcSEcCtD
Temozolomide—Asthenia—Bleomycin—melanoma	5.57e-05	0.00121	CcSEcCtD
Temozolomide—Angiopathy—Docetaxel—melanoma	5.56e-05	0.0012	CcSEcCtD
Temozolomide—Gastrointestinal pain—Carmustine—melanoma	5.54e-05	0.0012	CcSEcCtD
Temozolomide—Immune system disorder—Docetaxel—melanoma	5.53e-05	0.0012	CcSEcCtD
Temozolomide—Mediastinal disorder—Docetaxel—melanoma	5.52e-05	0.0012	CcSEcCtD
Temozolomide—Chills—Docetaxel—melanoma	5.5e-05	0.00119	CcSEcCtD
Temozolomide—Pruritus—Bleomycin—melanoma	5.49e-05	0.00119	CcSEcCtD
Temozolomide—Alopecia—Docetaxel—melanoma	5.41e-05	0.00117	CcSEcCtD
Temozolomide—Mental disorder—Docetaxel—melanoma	5.37e-05	0.00116	CcSEcCtD
Temozolomide—Abdominal pain—Carmustine—melanoma	5.35e-05	0.00116	CcSEcCtD
Temozolomide—Body temperature increased—Carmustine—melanoma	5.35e-05	0.00116	CcSEcCtD
Temozolomide—Malnutrition—Docetaxel—melanoma	5.33e-05	0.00115	CcSEcCtD
Temozolomide—Erythema—Docetaxel—melanoma	5.33e-05	0.00115	CcSEcCtD
Temozolomide—Hypersensitivity—Dactinomycin—melanoma	5.33e-05	0.00115	CcSEcCtD
Temozolomide—Dysgeusia—Docetaxel—melanoma	5.22e-05	0.00113	CcSEcCtD
Temozolomide—Asthenia—Dactinomycin—melanoma	5.19e-05	0.00112	CcSEcCtD
Temozolomide—Back pain—Docetaxel—melanoma	5.16e-05	0.00112	CcSEcCtD
Temozolomide—Hypersensitivity—Carmustine—melanoma	4.99e-05	0.00108	CcSEcCtD
Temozolomide—Diarrhoea—Dactinomycin—melanoma	4.95e-05	0.00107	CcSEcCtD
Temozolomide—Vomiting—Bleomycin—melanoma	4.93e-05	0.00107	CcSEcCtD
Temozolomide—Anaemia—Docetaxel—melanoma	4.93e-05	0.00107	CcSEcCtD
Temozolomide—Rash—Bleomycin—melanoma	4.89e-05	0.00106	CcSEcCtD
Temozolomide—Dermatitis—Bleomycin—melanoma	4.89e-05	0.00106	CcSEcCtD
Temozolomide—Asthenia—Carmustine—melanoma	4.86e-05	0.00105	CcSEcCtD
Temozolomide—Leukopenia—Docetaxel—melanoma	4.77e-05	0.00103	CcSEcCtD
Temozolomide—Palpitations—Docetaxel—melanoma	4.71e-05	0.00102	CcSEcCtD
Temozolomide—Cough—Docetaxel—melanoma	4.65e-05	0.00101	CcSEcCtD
Temozolomide—Diarrhoea—Carmustine—melanoma	4.63e-05	0.001	CcSEcCtD
Temozolomide—Convulsion—Docetaxel—melanoma	4.62e-05	0.001	CcSEcCtD
Temozolomide—Nausea—Bleomycin—melanoma	4.61e-05	0.000998	CcSEcCtD
Temozolomide—Hypertension—Docetaxel—melanoma	4.61e-05	0.000997	CcSEcCtD
Temozolomide—Vomiting—Dactinomycin—melanoma	4.6e-05	0.000996	CcSEcCtD
Temozolomide—Rash—Dactinomycin—melanoma	4.56e-05	0.000988	CcSEcCtD
Temozolomide—Myalgia—Docetaxel—melanoma	4.54e-05	0.000983	CcSEcCtD
Temozolomide—Arthralgia—Docetaxel—melanoma	4.54e-05	0.000983	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	4.51e-05	0.000976	CcSEcCtD
Temozolomide—Dizziness—Carmustine—melanoma	4.48e-05	0.00097	CcSEcCtD
Temozolomide—Dry mouth—Docetaxel—melanoma	4.44e-05	0.000961	CcSEcCtD
Temozolomide—Confusional state—Docetaxel—melanoma	4.39e-05	0.00095	CcSEcCtD
Temozolomide—Oedema—Docetaxel—melanoma	4.35e-05	0.000942	CcSEcCtD
Temozolomide—Anaphylactic shock—Docetaxel—melanoma	4.35e-05	0.000942	CcSEcCtD
Temozolomide—Infection—Docetaxel—melanoma	4.32e-05	0.000936	CcSEcCtD
Temozolomide—Vomiting—Carmustine—melanoma	4.31e-05	0.000932	CcSEcCtD
Temozolomide—Nausea—Dactinomycin—melanoma	4.3e-05	0.000931	CcSEcCtD
Temozolomide—Rash—Carmustine—melanoma	4.27e-05	0.000925	CcSEcCtD
Temozolomide—Nervous system disorder—Docetaxel—melanoma	4.27e-05	0.000924	CcSEcCtD
Temozolomide—Dermatitis—Carmustine—melanoma	4.27e-05	0.000924	CcSEcCtD
Temozolomide—Thrombocytopenia—Docetaxel—melanoma	4.26e-05	0.000923	CcSEcCtD
Temozolomide—Headache—Carmustine—melanoma	4.24e-05	0.000919	CcSEcCtD
Temozolomide—Skin disorder—Docetaxel—melanoma	4.23e-05	0.000915	CcSEcCtD
Temozolomide—Anorexia—Docetaxel—melanoma	4.15e-05	0.000898	CcSEcCtD
Temozolomide—Nausea—Carmustine—melanoma	4.02e-05	0.000871	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Docetaxel—melanoma	3.97e-05	0.000859	CcSEcCtD
Temozolomide—Insomnia—Docetaxel—melanoma	3.94e-05	0.000852	CcSEcCtD
Temozolomide—Paraesthesia—Docetaxel—melanoma	3.91e-05	0.000846	CcSEcCtD
Temozolomide—Dyspnoea—Docetaxel—melanoma	3.88e-05	0.00084	CcSEcCtD
Temozolomide—Somnolence—Docetaxel—melanoma	3.87e-05	0.000838	CcSEcCtD
Temozolomide—Dyspepsia—Docetaxel—melanoma	3.83e-05	0.000829	CcSEcCtD
Temozolomide—Decreased appetite—Docetaxel—melanoma	3.78e-05	0.000819	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Docetaxel—melanoma	3.76e-05	0.000814	CcSEcCtD
Temozolomide—Fatigue—Docetaxel—melanoma	3.75e-05	0.000812	CcSEcCtD
Temozolomide—Pain—Docetaxel—melanoma	3.72e-05	0.000806	CcSEcCtD
Temozolomide—Constipation—Docetaxel—melanoma	3.72e-05	0.000806	CcSEcCtD
Temozolomide—Feeling abnormal—Docetaxel—melanoma	3.59e-05	0.000777	CcSEcCtD
Temozolomide—Gastrointestinal pain—Docetaxel—melanoma	3.56e-05	0.000771	CcSEcCtD
Temozolomide—Abdominal pain—Docetaxel—melanoma	3.44e-05	0.000745	CcSEcCtD
Temozolomide—Body temperature increased—Docetaxel—melanoma	3.44e-05	0.000745	CcSEcCtD
Temozolomide—Hypersensitivity—Docetaxel—melanoma	3.21e-05	0.000694	CcSEcCtD
Temozolomide—Asthenia—Docetaxel—melanoma	3.12e-05	0.000676	CcSEcCtD
Temozolomide—Pruritus—Docetaxel—melanoma	3.08e-05	0.000667	CcSEcCtD
Temozolomide—Diarrhoea—Docetaxel—melanoma	2.98e-05	0.000645	CcSEcCtD
Temozolomide—Dizziness—Docetaxel—melanoma	2.88e-05	0.000623	CcSEcCtD
Temozolomide—Vomiting—Docetaxel—melanoma	2.77e-05	0.000599	CcSEcCtD
Temozolomide—Rash—Docetaxel—melanoma	2.74e-05	0.000594	CcSEcCtD
Temozolomide—Dermatitis—Docetaxel—melanoma	2.74e-05	0.000594	CcSEcCtD
Temozolomide—Headache—Docetaxel—melanoma	2.73e-05	0.00059	CcSEcCtD
Temozolomide—Nausea—Docetaxel—melanoma	2.59e-05	0.00056	CcSEcCtD
